OBJECTIVE: To assess whether or not a genetic risk score that was previously shown to be associated with myocardial infarction (MI) and coronary artery disease (CAD) is also associated with markers of carotid atherosclerosis. DESIGN: A total of 4022 middle-aged subjects from the general Swedish population were genotyped and individually assigned a genetic risk score based on 13 single-nucleotide polymorphisms (SNPs), previously associated with MI and CAD. The genetic score (Score-MI) was then related to carotid bulb intima-media thickness (IMT), common carotid artery (CCA) IMT and to the occurrence of carotid plaques in the study population. RESULTS: Score-MI was associated with IMT of the bulb (P < 0.001) and the CCA (P < 0.001) in unadjusted analyses, and with IMT of the bulb after adjustment for cardiovascular risk factors (P = 0.003). The effect size of Score-MI on IMT of the bulb was similar to that of LDL cholesterol. After adjustment for cardiovascular risk factors, Score-MI was also associated with the occurrence of carotid plaques (odds ratio per quintile of Score-MI = 1.11; 95% confidence interval 1.04-1.18; P = 0.001). In addition to SNPs with known effects on LDL levels, Score-MI showed nominal associations with increasing systolic blood pressure and decreasing C-reactive protein levels. CONCLUSIONS: This genetic risk score was independently associated with carotid bulb IMT and carotid plaques, providing evidence of an association with early markers of atherosclerosis. This might imply that the genetic MI risk conferred by the score is related to early atherosclerosis and that the risk score may identify at an early stage candidates at risk of developing intermediate phenotypes of atherosclerosis. Further studies should test whether or not assessing the genetic score could be valuable for early treatment decisions in these subjects.
OBJECTIVE: To assess whether or not a genetic risk score that was previously shown to be associated with myocardial infarction (MI) and coronary artery disease (CAD) is also associated with markers of carotid atherosclerosis. DESIGN: A total of 4022 middle-aged subjects from the general Swedish population were genotyped and individually assigned a genetic risk score based on 13 single-nucleotide polymorphisms (SNPs), previously associated with MI and CAD. The genetic score (Score-MI) was then related to carotid bulb intima-media thickness (IMT), common carotid artery (CCA) IMT and to the occurrence of carotid plaques in the study population. RESULTS: Score-MI was associated with IMT of the bulb (P < 0.001) and the CCA (P < 0.001) in unadjusted analyses, and with IMT of the bulb after adjustment for cardiovascular risk factors (P = 0.003). The effect size of Score-MI on IMT of the bulb was similar to that of LDL cholesterol. After adjustment for cardiovascular risk factors, Score-MI was also associated with the occurrence of carotid plaques (odds ratio per quintile of Score-MI = 1.11; 95% confidence interval 1.04-1.18; P = 0.001). In addition to SNPs with known effects on LDL levels, Score-MI showed nominal associations with increasing systolic blood pressure and decreasing C-reactive protein levels. CONCLUSIONS: This genetic risk score was independently associated with carotid bulb IMT and carotid plaques, providing evidence of an association with early markers of atherosclerosis. This might imply that the genetic MI risk conferred by the score is related to early atherosclerosis and that the risk score may identify at an early stage candidates at risk of developing intermediate phenotypes of atherosclerosis. Further studies should test whether or not assessing the genetic score could be valuable for early treatment decisions in these subjects.
Authors: N Yiannakouris; M Katsoulis; V Dilis; L D Parnell; D Trichopoulos; J M Ordovas; A Trichopoulou Journal: Atherosclerosis Date: 2012-02-28 Impact factor: 5.162
Authors: Bartłomiej Kisiel; Robert Kruszewski; Aleksandra Juszkiewicz; Anna Raczkiewicz; Artur Bachta; Krzysztof Kłos; Krzysztof Duda; Artur Maliborski; Konrad Szymański; Rafał Płoski; Marek Saracyn; Stanisław Niemczyk; Katarzyna Kisiel; Małgorzata Tłustochowicz; Witold Tłustochowicz Journal: Rheumatol Int Date: 2018-10-29 Impact factor: 2.631
Authors: Eythor Bjornsson; Daniel F Gudbjartsson; Anna Helgadottir; Thorarinn Gudnason; Tomas Gudbjartsson; Kristjan Eyjolfsson; Riyaz S Patel; Nima Ghasemzadeh; Gudmar Thorleifsson; Arshed A Quyyumi; Unnur Thorsteinsdottir; Gudmundur Thorgeirsson; Kari Stefansson Journal: Arterioscler Thromb Vasc Biol Date: 2015-04-16 Impact factor: 8.311
Authors: Lars Lind; Bruna Gigante; Yan Borné; Tobias Feldreich; Jerzy Leppert; Pär Hedberg; Carl Johan Östgren; Fredrik H Nyström; Johan Sundström; Johan Ärnlöv; Damiano Baldassarre; Elena Tremoli; Fabrizio Veglia; Anders Hamsten; Christopher J O'Donnell; Nora Franceschini; Marju Orho-Melander; Jan Nilsson; Olle Melander; Gunnar Engström; Anders Mälarstig Journal: Arterioscler Thromb Vasc Biol Date: 2021-03-04 Impact factor: 8.311
Authors: Morten Krogh Christiansen; Louise Nissen; Simon Winther; Peter Loof Møller; Lars Frost; Jane Kirk Johansen; Henrik Kjærulf Jensen; Daníel Guðbjartsson; Hilma Holm; Kári Stefánsson; Hans Erik Bøtker; Morten Bøttcher; Mette Nyegaard Journal: J Am Heart Assoc Date: 2020-01-25 Impact factor: 5.501
Authors: Marcel den Hoed; Rona J Strawbridge; Peter Almgren; Stefan Gustafsson; Tomas Axelsson; Gunnar Engström; Ulf de Faire; Bo Hedblad; Steve E Humphries; Cecilia M Lindgren; Andrew P Morris; Gerd Östling; Ann-Christine Syvänen; Elena Tremoli; Anders Hamsten; Erik Ingelsson; Olle Melander; Lars Lind Journal: Atherosclerosis Date: 2015-01-31 Impact factor: 5.162